Oncoscience
Navigate

Freeing Oncology from Publication Cost

Volume 13, Issue 0
Volume 13, Issue 0

MISSION

Oncoscience is an open-access traditional journal with a special mission: freeing oncology from publication cost. It is free for the readers and the authors.

  • Oncoscience applies the recommendations of the Committee on Publication Ethics (COPE) to all works we publish.
  • The Editorial Board includes 20 members of the National Academy of Sciences USA, 6 Lasker Award winners, Nobel Prize winner (Andrew Schally) and other renowned scientists.
  • Oncoscience has published papers by John C. Reed, Tony Hunter, Andrew V. Schally (Nobel Prize winner) and other outstanding authors.
  • During the history of Oncoscience, a number of our members have also joined the National Academy of Sciences USA, and have won Lasker, Nobel and other prestigious awards.
  • Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.
  • Impact Journals is a member of the Society for Scholarly Publishing.

Introducing Oncoscience — the journal's inaugural editorial.

ARCHIVING & INDEXING

  • PubMed and PubMed Central
  • META (Chan Zuckerberg Initiative) (2018-2022). META database was discontinued in 2022.
  • Dimensions (Digital Science)

FREE ALTMETRIC ARTICLE REPORTS

We offer Free Altmetric Article Reports to all of our authors and readers. These reports offer real-time feedback that contain a summary of data regarding the online engagement relating to a particular publication.

Resources on: Altmetric Analytic Software, Adding Altmetric data to your NIH Biosketch, What is the Altmetric donut and How is your Altmetric score calculated.

Editors' Choice
Editors' Choice
Most Popular DOIs of 2025 (Crossref Data)

H2Bub1: Guardian of Chromatin Accessibility in Ovarian Cancer

10.18632/oncoscience.484

Cultural carcinogens in oral squamous cell carcinoma risk across global populations

10.18632/oncoscience.662

The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma

10.18632/oncoscience.663

Cervical angioleiomyoma: A rare tumor behind persistent menorrhagia and pelvic pain

10.18632/oncoscience.659

Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression

10.18632/oncoscience.661

Combined hepatocellular-cholangiocarcinoma: A rare and challenging diagnostic entity- A case report

10.18632/oncoscience.658

Enhancing breast cancer detection with AI for early diagnosis and recurrence prediction

10.18632/oncoscience.660

Modifiable risk factors of prostate cancer: Insights from a hospital-based study

10.18632/oncoscience.657

Ileal leiomyoma disguised as intussusception: Imaging pitfalls in a 28-year-old female

10.18632/oncoscience.656

Sebaceous adenoma of the eyelid: A clinical, histopathological, and immunohistochemical perspective

10.18632/oncoscience.655